Cardioversion of Atrial Fibrillation and Subsequent Maintenance of Sinus Rbythm
- 1 October 1997
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 20 (10) , 2675-2683
- https://doi.org/10.1111/j.1540-8159.1997.tb06116.x
Abstract
This article gives an overview of electrical cardioversion of AF and includes the discussion of newer strategies. DC external cardioversion is highly effective and carries a low risk of complications. Other approaches, like transesophageal cardioversion and high energy internal cardioversion, may improve the acute success rate but do not enhance long-term maintenance of sinus rhythm compared to external cardioversion. An atrial defibrillator may have important advantages which relate to the fact that the duration and possibly also the number of AF episodes become reduced. Supposedly, shortening the attacks of AF may exert an antiarrhythmic effect by limiting electrical, anatomical, and neurohumoral remodeling. So far, low energy biatrial defibrillation using an atrial defibrillator seems to be effective and safe (i.e., does not induce ventricular arrhythmias). However, discomfort limits its tolerability in clinical practice. Future improvement of leads and light sedation that is easy to administer may overcome this problem. In the second part of this overview, the probability of AF recurrence using a serial cardioversion approach is discussed. In middle-aged patients with a fair exercise tolerance and an arrhythmia duration < than 36 months this approach may be worthwhile. Young patients (age < 57 years) with an arrhythmia duration < 3 months and without hypertension may be cured from the arrhythmia with a single shock and without the institution of antiarrhythmic drugs. However, the serial electrical cardioversion approach is unlikely to succeed in elderly patients with a duration of AF exceeding 36 months and a poor exercise tolerance (NYHA Functional Class III or IV).Keywords
This publication has 43 references indexed in Scilit:
- Time course of troponin I, myoglobin, and cardiac enzyme release after electrical cardioversionThe American Journal of Cardiology, 1996
- Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillationThe American Journal of Cardiology, 1993
- Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dogAmerican Heart Journal, 1992
- Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1992
- Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutterThe American Journal of Cardiology, 1991
- Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1989
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortalityAmerican Heart Journal, 1988
- Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1986